222 related articles for article (PubMed ID: 17163255)
1. Oral ciprofloxacin affects the pharmacokinetics of paracetamol in saliva.
Issa MM; Nejem RM; El-Abadla NS
Clin Drug Investig; 2006; 26(4):223-6. PubMed ID: 17163255
[TBL] [Abstract][Full Text] [Related]
2. Effects of paracetamol on the pharmacokinetics of ciprofloxacin in plasma using a microbiological assay.
Issa MM; Nejem RM; El-Abadla NS; El-Naby MK; Roshdy AA; Kheiralla ZA
Clin Drug Investig; 2007; 27(7):463-7. PubMed ID: 17563126
[TBL] [Abstract][Full Text] [Related]
3. Effects of iron on the pharmacokinetics of paracetamol in saliva.
Issa MM; Nejem RM; Shanab AA
Pak J Biol Sci; 2013 Dec; 16(24):2050-3. PubMed ID: 24517028
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin bioavailability is enhanced by oral co-administration with phenazopyridine: a pharmacokinetic study in a Mexican population.
Marcelín-Jiménez G; Angeles AP; Martínez-Rossier L; Fernández S A
Clin Drug Investig; 2006; 26(6):323-8. PubMed ID: 17163266
[TBL] [Abstract][Full Text] [Related]
5. Saliva vs. plasma bioequivalence of paracetamol in humans: validation of class I drugs of the salivary excretion classification system.
Idkaidek N; Arafat T
Drug Res (Stuttg); 2014 Oct; 64(10):559-62. PubMed ID: 24452519
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of Oral and Intravenous Paracetamol (Acetaminophen) When Co-Administered with Intravenous Morphine in Healthy Adult Subjects.
Raffa RB; Pawasauskas J; Pergolizzi JV; Lu L; Chen Y; Wu S; Jarrett B; Fain R; Hill L; Devarakonda K
Clin Drug Investig; 2018 Mar; 38(3):259-268. PubMed ID: 29214506
[TBL] [Abstract][Full Text] [Related]
7. Effect of study protocol on the interactions between cimetidine and paracetamol in man.
Garba M; Odunola MT; Ahmed BH
Eur J Drug Metab Pharmacokinet; 1999; 24(2):159-62. PubMed ID: 10510744
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
9. Report: pharmacokinetic and drug interaction studies of pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan.
Gauhar S; Ali SA; Naqvi SB; Shoaib MH
Pak J Pharm Sci; 2014 Mar; 27(2):389-95. PubMed ID: 24577931
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic interaction of ciprofloxacin with diclofenac: a single-dose, two-period crossover study in healthy adult volunteers.
Iqbal Z; Khan A; Naz A; Khan JA; Khan GS
Clin Drug Investig; 2009; 29(4):275-81. PubMed ID: 19301941
[TBL] [Abstract][Full Text] [Related]
11. Influence of menstrual cycle on the pharmacokinetics of paracetamol through salivary compartment in healthy subjects.
Gugilla SR; Boinpally RR; Bolla SM; Devaraj R
Ther Drug Monit; 2002 Aug; 24(4):497-501. PubMed ID: 12142633
[TBL] [Abstract][Full Text] [Related]
12. Importance of entero-salivary recirculation in paracetamol pharmacokinetics.
Schaiquevich P; Niselman A; Rubio M
Biopharm Drug Dispos; 2002 Sep; 23(6):245-9. PubMed ID: 12214325
[TBL] [Abstract][Full Text] [Related]
13. The comparative pharmacokinetics of modified-release and immediate-release paracetamol in a simulated overdose model.
Chiew A; Day P; Salonikas C; Naidoo D; Graudins A; Thomas R
Emerg Med Australas; 2010 Dec; 22(6):548-55. PubMed ID: 21143403
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of two new formulations of paracetamol, compared with three marketed formulations, in healthy volunteers.
Sevilla-Tirado FJ; González-Vallejo EB; Leary AC; Breedt HJ; Hyde VJ; Fernández-Hernando N
Methods Find Exp Clin Pharmacol; 2003 Sep; 25(7):531-5. PubMed ID: 14571283
[TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacokinetics of Panadol Extend and immediate-release paracetamol in a simulated overdose model.
Tan C; Graudins A
Emerg Med Australas; 2006 Aug; 18(4):398-403. PubMed ID: 16842311
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs.
Papich MG
Am J Vet Res; 2012 Jul; 73(7):1085-91. PubMed ID: 22738062
[TBL] [Abstract][Full Text] [Related]
17. Drug absorption may be delayed after stroke: results of the paracetamol absorption test.
Crome P; Rizeq M; George S; Braithwaite RA; Jones PW
Age Ageing; 2001 Sep; 30(5):391-3. PubMed ID: 11709376
[TBL] [Abstract][Full Text] [Related]
18. A five way crossover human volunteer study to compare the pharmacokinetics of paracetamol following oral administration of two commercially available paracetamol tablets and three development tablets containing paracetamol in combination with sodium bicarbonate or calcium carbonate.
Grattan T; Hickman R; Darby-Dowman A; Hayward M; Boyce M; Warrington S
Eur J Pharm Biopharm; 2000 May; 49(3):225-9. PubMed ID: 10799813
[TBL] [Abstract][Full Text] [Related]
19. Target site concentrations of ciprofloxacin after single intravenous and oral doses.
Brunner M; Stabeta H; Möller JG; Schrolnberger C; Erovic B; Hollenstein U; Zeitlinger M; Eichler HG; Müller M
Antimicrob Agents Chemother; 2002 Dec; 46(12):3724-30. PubMed ID: 12435668
[TBL] [Abstract][Full Text] [Related]
20. The influence of morphine on the absorption of paracetamol from various formulations in subjects in the supine position, as assessed by TDx measurement of salivary paracetamol concentrations.
Kennedy JM; Tyers NM; Davey AK
J Pharm Pharmacol; 2003 Oct; 55(10):1345-50. PubMed ID: 14607015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
